Abstract:ABSTRACT Specific pathogen-free (SPF) laboratory mice dominate preclinical studies for immunology and vaccinology. Unfortunately, SPF mice often fail to accurately model human responses to vaccination and other immunological perturbations. Several groups have taken different approaches to introduce additional microbial experience to SPF mice to better model human immune experience. How these different models compare is unknown. Here, we directly compare three models: housing SPF mice in a microbe-rich barn-like environment (feralizing), adding wild-caught mice to the barn-like environment (fer-cohoused), or cohousing SPF mice with pet store mice in a barrier facility (pet-cohoused); the two latter representing different murine sources of microbial transmission. Pet-cohousing mice resulted in the greatest microbial exposure. Feralizing alone did not result in the transmission of any pathogens tested, while fer-cohousing resulted in the transmission of several picornaviruses. Murine astrovirus 2, the most common pathogen from pet store mice, was absent from the other two model systems. Previously, we had shown that pet-cohousing reduced the antibody response to vaccination compared with SPF mice. This was not recapitulated in either the feralized or fer-cohoused mice. These data indicate that not all dirty mouse models are equivalent in either microbial experience or immune responses to vaccination. These disparities suggest that more cross model comparisons are needed but also represent opportunities to uncover microbe combination-specific phenotypes and develop more refined experimental models. Given the breadth of microbes encountered by humans across the globe, multiple model systems may be needed to accurately recapitulate heterogenous human immune responses. IMPORTANCE Animal models are an essential tool for evaluating clinical interventions. Unfortunately, they can often fail to accurately predict outcomes when translated into humans. This failure is due in part to a lack of natural infections experienced by most laboratory animals. To improve the mouse model, we and others have exposed laboratory mice to microbes they would experience in the wild. Although these models have been growing in popularity, these different models have not been specifically compared. Here, we directly compare how three different models of microbial experience impact the immune response to influenza vaccination. We find that these models are not the same and that the degree of microbial exposure affects the magnitude of the response to vaccination. These results provide an opportunity for the field to continue comparing and contrasting these systems to determine which models best recapitulate different aspects of the human condition.

Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response

Sequential early-life viral infections modulate the microbiota and adaptive immune responses to systemic and mucosal vaccination

Comparison of mouse models of microbial experience reveals differences in microbial diversity and response to vaccination

Normalizing the environment recapitulates adult human immune traits in laboratory mice

Making Mouse Models That Reflect Human Immune Responses

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

Longitudinal Single-Cell Transcriptomics of Gamma Herpesvirus Infection in Mouse Lungs

Virological, innate, and adaptive immune profiles shaped by variation in route and age of host in murine cytomegalovirus infection

Laboratory mice born to wild mice have natural microbiota and model human immune responses

Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection

Altered immunity of laboratory mice in the natural environment is associated with fungal colonization

Diverse Heterologous Primary Infections Radically Alter Immunodominance Hierarchies and Clinical Outcomes Following H7N9 Influenza Challenge in Mice

Murine models of Pneumocystis infection recapitulate human primary immune disorders

A transgenic mouse with a humanised B cell repertoire mounts an antibody response to influenza infection and vaccination

Novel Mouse Model of Recurrent Sublethal Herpes Simplex Virus Infection Recapitulates Human Antibody Responses to Primary and Chronic Infection

Immune determinants of pegivirus persistence, control, and cross-species infection in the laboratory mouse

Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse

Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19

Genetic and environmental interactions contribute to immune variation in rewilded mice

Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection

Phenotypic and transcriptional changes in peripheral blood mononuclear cells during alphavirus encephalitis in mice